Incessant ovulation and ovarian cancer - a hypothesis re-visited

被引:0
|
作者
Fathalla, M. F. [1 ]
机构
[1] Assiut Univ, Obstet & Gynaecol, PO 30, Assiut, Egypt
关键词
Incessant ovulation; prevention; oral contraception; ovarian cancer;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian cancer continues to be a silent killer. Most women have advanced disease at the time of diagnosis. Intensive efforts to develop effective screening strategies have not so far met with success. There is a need to re-visit the potential of prevention strategies. In 1971, the author submitted a hypothesis for a possible relationship between incessant ovulation and development of epithelial ovarian cancer. Subsequent research from different disciplines opened new frontiers to be explored for prevention in the general population and in high-risk groups, and for opportunistic interventions. The protective effect of oral contraceptive pills has been well documented. Widespread use of the pill in the past several decades is credited with a fall in the incidence of ovarian cancer in the general population, countering the effect of low parity. Removing the barriers against contraceptive access and satisfying the still unmet contraceptive need could expand the protective coverage. Enhanced understanding of the biological mechanisms involved in process of ovulation offers the promise of non-hormonal pharmacologic suppression of follicle rupture for women who have risk factors and do not need contraception. The evidence for a possible origin of epithelial cancer in the fimbria of the Fallopian tube presents an opportunity for preventive intervention, during hysterectomy, where salpingectomy alone may provide protection while one or both ovaries are conserved. Finally, the incessant ovulator egg-laying hen has demonstrated its potential as an experimental model for chemoprevention of epithelial ovarian cancer.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 50 条
  • [21] A data review and re-assessment of ovarian cancer serum proteomic profiling
    James M Sorace
    Min Zhan
    BMC Bioinformatics, 4
  • [22] Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
    Nathan J Bowen
    L DeEtte Walker
    Lilya V Matyunina
    Sanjay Logani
    Kimberly A Totten
    Benedict B Benigno
    John F McDonald
    BMC Medical Genomics, 2
  • [23] Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients
    Hansen, Mads Kingo Guldberg
    Smerdel, Maja Patricia
    Waldstrom, Marianne
    Andersen, Rikke Fredslund
    Adimi, Parvin
    Jakobsen, Anders
    Steffensen, Karina Dahl
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (06) : 751 - 759
  • [24] A diagnostic dilemma of a pulmonary nodule of a patient who suffered advanced ovarian cancer: A case report and a hypothesis
    Xiong, Shengchun
    Tang, Keiyui
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2022, 94
  • [25] Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients
    Mads Kingo Guldberg Hansen
    Maja Patricia Smerdel
    Marianne Waldstrøm
    Rikke Fredslund Andersen
    Parvin Adimi
    Anders Jakobsen
    Karina Dahl Steffensen
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 751 - 759
  • [26] In silico detection of potential prognostic circRNAs through a re-annotation strategy in ovarian cancer
    Guo, Qiuyan
    He, Yanan
    Sun, Liyuan
    Kong, Congcong
    Cheng, Yan
    Zhang, Guangmei
    ONCOLOGY LETTERS, 2019, 17 (04) : 3677 - 3686
  • [27] Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance
    See, HT
    Freedman, RS
    Kudelka, AP
    Burke, TW
    Gershenson, DM
    Tangjitgamol, S
    Kavanagh, JJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) : 209 - 216
  • [28] Declining CA-125 in an ovarian cancer patient with progression of measurable disease: A rational hypothesis for discordant results
    Markman, M
    Kennedy, A
    Webster, K
    Peterson, C
    Kulp, B
    Belinson, J
    GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 321 - 322
  • [29] Ovarian cancer in infertile women during or after ovulation-induction therapy: expression of LH/hCG receptors and sex steroid receptors
    Kuroda, H
    Konishi, I
    Mandai, M
    Nanbu, K
    Rao, CV
    Mori, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (06) : 451 - 457
  • [30] Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort
    Trabert, Britton
    Lamb, Emmet J.
    Scoccia, Bert
    Moghissi, Kamran S.
    Westhoff, Carolyn L.
    Niwa, Shelley
    Brinton, Louise A.
    FERTILITY AND STERILITY, 2013, 100 (06) : 1660 - 1666